Putnam Investment Management LLC recently announced the acquisition of new stake in Eastman Chemical Company (NYSE:EMN). The institutional investor has increased its shareholding in the Basic Materials company by 13.16% to 4.1 million shares with purchase of 0.48 million shares. This fresh investment now brings its stake to 3.45% valued currently at $349.04 million. In addition, Invesco Capital Management LLC raised its holdings by 0.43 million to 2.21 million shares. And Dimensional Fund Advisors LP has lifted its position by 10.78% or 0.21 million shares – to 2.11 million shares.
With over 2.24 million Eastman Chemical Company (EMN) shares trading Tuesday and a closing price of $82.88 on the day, the dollar volume was approximately $185.47 million. The shares have shown a negative half year performance of -12.64% and its price on 03/14/23 gained nearly 4.00%. Currently, there are 119.30M common shares owned by the public and among those 118.11M shares have been available to trade.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 22 analysts who have offered their price forecasts for EMN have a consensus price objective of $95.20. The analysts have set the share’s price value over the next 12 months at a high of $115.00 and a low of $80.00. The average price target is 13.15% above its recent price level and a downside to the estimated low will see the stock lose -3.6% over that period. But an upside of 27.93% will see the stock hit the forecast high price target while median target price for the stock is $93.50.
Insiders at the company have transacted a total of 27 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 14 of these insider trades were purchases, accounting for 181,189 shares. Insider sales of the common stock occurred on 13 occasions, with total insider shares sold totaling 74,213 shares.
The top 3 mutual fund holders in Eastman Chemical Company are Vanguard Total Stock Market Index, Vanguard Mid Cap Index Fund, and Vanguard 500 Index Fund. Vanguard Total Stock Market Index owns 3.69 million shares of the company’s stock, all valued at over $314.41 million. The company bought an additional 45939.0 shares recently to bring their total holdings to about 3.11% of the shares outstanding. Vanguard Mid Cap Index Fund bought 4515.0 shares to see its total holdings expand to 2.79 million shares valued at over $238.11 million and representing 2.35% of the shares outstanding. Vanguard 500 Index Fund bought 6593.0 shares to bring its total holdings to over 2.78 million shares at a value of $236.86 million. Vanguard 500 Index Fund now owns shares totaling to 2.34% of the shares outstanding.
Shares of Eastman Chemical Company (NYSE: EMN) opened at $81.37, up $1.68 from a prior closing price of $79.69. However, the script later moved the day high at 84.86, up 4.00%. The company’s stock has a 5-day price change of 0.56% and -2.69% over the past three months. EMN shares are trading 1.77% year to date (YTD), with the 12-month market performance down to -21.38% lower. It has a 12-month low price of $69.91 and touched a high of $114.97 over the same period. EMN has an average intraday trading volume of 986.98K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.39%, -4.78%, and -5.34% respectively.
Institutional ownership of Eastman Chemical Company (NYSE: EMN) shares accounts for 87.80% of the company’s 119.30M shares outstanding. Mutual fund holders own 37.99%, while other institutional holders and individual stakeholders account for 48.13% and 2.03% respectively.
It has a market capitalization of $10.07B and a beta (3y monthly) value of 1.52. The stock’s trailing 12-month PE ratio is 13.17, while the earnings-per-share (ttm) stands at $6.29. The company has a PEG of 3.36 and a Quick Ratio of 0.60 with the debt-to-equity ratio at 1.00. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.68% over the week and 2.76% over the month.
Analysts forecast that Eastman Chemical Company (EMN) will achieve an EPS of $1.16 for the current quarter, $2.11 for the next quarter and $8.87 for 2024. The lowest estimate earnings-per-share for the quarter is $1.05 while analysts give the company a high EPS estimate of $1.38. Comparatively, EPS for the current quarter was $2.06 a year ago. Earnings per share for the fiscal year are expected to increase by 1.60%, and 14.36% over the next financial year. EPS should grow at an annualized rate of 3.91% over the next five years, compared to -2.40% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 22 brokerage firm advisors rate Eastman Chemical Company (EMN) as a “Moderate Buy” at a consensus score of 2.50. Specifically, 8 Wall Street analysts polled rate the stock as a buy, while 14 of the 22 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the EMN, a number of firms have released research notes about the stock. Vertical Research stated their Hold rating for the stock in a research note on January 30, 2023, with the firm’s price target at $94-$92. Scotiabank coverage for the Eastman Chemical Company (EMN) stock in a research note released on January 30, 2023 offered a Sector Perform rating with a price target of $90. Goldman on their part issued Neutral rating on October 13, 2022.
